Matthew Coghlan's Location
Indianapolis, Indiana, United States
Matthew Coghlan's Work
Matthew Coghlan's Education
Harvard Medical School
Royal Society NATO Post-Doctoral Fellow (PI3K and small G-protein signal transduction)
1995 - 1997
University of Cambridge
PhD (Molecular mechanism of insulin resistance)
1991 - 1994
Imperial College London
BSc (Hons) 1st Class (Biochemistry)
1986 - 1989
Matthew Coghlan's Skills
Matthew Coghlan's Summary
Matthew Coghlan, based in Indianapolis, Indiana, United States, is currently a Vice President - Head Incretin Portfolio Science at Eli Lilly and Company, bringing experience from previous roles at Novo Nordisk, MedImmune and AstraZeneca. Matthew Coghlan holds a 1995 - 1997 Royal Society NATO Post-Doctoral Fellow in PI3K and small G-protein signal transduction @ Harvard Medical School. With a robust skill set that includes Cross-functional Team Leadership, Drug Discovery, Lead Change, Biopharmaceuticals, Pharmacology and more, Matthew Coghlan contributes valuable insights to the industry. Matthew Coghlan has 2 emails on RocketReach.